Key statistics
On Tuesday, Biohaven Ltd (BHVN:NYQ) closed at 45.23, -27.29% below its 52-week high of 62.21, set on Mar 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 40.80 |
---|---|
High | 47.44 |
Low | 40.80 |
Bid | 43.89 |
Offer | 45.20 |
Previous close | 45.59 |
Average volume | 1.02m |
---|---|
Shares outstanding | 98.40m |
Free float | 82.69m |
P/E (TTM) | -- |
Market cap | 4.49bn USD |
EPS (TTM) | -9.35 USD |
Data delayed at least 15 minutes, as of Nov 26 2024.
More ▼
- Biohaven Provides Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity
- Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments
- Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
- Biohaven Announces Pricing of $250 Million Public Offering of Common Shares
- Biohaven Announces Proposed Public Offering of Common Shares
- Biohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine
- Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
- Biohaven Announces Conference Call to Discuss Topline Pivotal Study Results in Spinocerebellar Ataxia
More ▼